Longitudinal model–based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer

被引：0
|
作者：
Wenjun Chen
Liang Li
Shuangmin Ji
Xuyang Song
Wei Lu
Tianyan Zhou
机构：
[1] Peking University,Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery System, Department of Pharmaceutics, School of Pharmaceutical Sciences
[2] National Medical Products Administration,Center for Drug Evaluation
[3] University of Florida,Department of Pharmaceutics, College of Pharmacy
来源：
European Journal of Clinical Pharmacology | 2020年 / 76卷
关键词：
Model-based meta-analysis; Castration-resistant prostate cancer; Progression-free survival; Overall survival; Longitudinal data;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：589 / 601
页数：12
相关论文
共 50 条
  • [31] Androgens and Overall Survival in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Docetaxel
    Ryan, Charles J.
    Dutta, Sandipan
    Kelly, William K.
    Middleberg, Rob
    Russell, Carly
    Morris, Michael J.
    Taplin, Mary-Ellen
    Halabi, Susan
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 222 - +
  • [32] The efficacy and safety comparison of docetaxel, cabazitaxel, estramustine, and mitoxantrone for castration-resistant prostate cancer: A network meta-analysis
    Song, Pan
    Huang, Chuiguo
    Wang, Yan
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 56 : 133 - 140
  • [33] Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
    Rodriguez-Vida, Alejo
    Galazi, Myria
    Rudman, Sarah
    Chowdhury, Simon
    Sternberg, Cora N.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3325 - 3339
  • [34] Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival
    Xie, Wanling
    Stopsack, Konrad H.
    Drouin, Sarah J.
    Fu, Henry
    Pomerantz, Mark M.
    Mucci, Lorelei A.
    Lee, Gwo-Shu M.
    Kantoff, Philip W.
    PROSTATE, 2019, 79 (01) : 73 - 80
  • [35] Real world treatment utilization patterns in patients with castration-resistant prostate cancer
    Vigneswaran, Hari T.
    Warnqvist, Anna
    Andersson, Therese M. L.
    Leval, Amy
    Eklund, Martin
    Nordstrom, Tobias
    Eloranta, Sandra
    Schain, Frida
    Dearden, Lindsay
    Liwing, Johan
    Mehra, Maneesha
    Nair, Sandhya
    Pettersson, Andreas
    Akre, Olof
    Aly, Markus
    SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (04) : 299 - 306
  • [36] Docetaxel Rechallenge Improves Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study
    Hung, Sheng-Chun
    Chang, Li-Wen
    Li, Jian-Ri
    Wang, Shian-Shiang
    Yang, Cheng-Kuang
    Chen, Chuan-Shu
    Lu, Kevin
    Chen, Cheng-Che
    Wang, Shu-Chi
    Lin, Chia-Yen
    Chen-Li Cheng
    Ou, Yen-Chuan
    Chiu, Kun-Yuan
    IN VIVO, 2021, 35 (06): : 3509 - 3519
  • [37] Preliminary Results of Tranilast Treatment for Patients with Advanced Castration-resistant Prostate Cancer
    Izumi, Kouji
    Mizokami, Atsushi
    Shima, Takashi
    Narimoto, Kazutaka
    Sugimoto, Kazuhiro
    Kobori, Yoshitomo
    Maeda, Yuji
    Konaka, Hiroyuki
    Koh, Eitetsu
    Namiki, Mikio
    ANTICANCER RESEARCH, 2010, 30 (07) : 3077 - 3081
  • [38] Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer
    Lucarelli, Giuseppe
    Ditonno, Pasquale
    Bettocchi, Carlo
    Spilotros, Marco
    Rutigliano, Monica
    Vavallo, Antonio
    Galleggiante, Vanessa
    Fanelli, Margherita
    Larocca, Angela Maria Vittoria
    Germinario, Cinzia Annatea
    Maiorano, Eugenio
    Selvaggi, Francesco Paolo
    Battaglia, Michele
    FUTURE ONCOLOGY, 2013, 9 (06) : 899 - 907
  • [39] No survival benefit found after extended treatment with docetaxel for patients with castration-resistant prostate cancer
    Tanaka, Masatoshi
    Kimura, Takahiro
    Iwamura, Yumina
    Enei, Yuki
    Iwamoto, Yuya
    Imai, Yu
    Inaba, Yuzo
    Matsukawa, Akihiro
    Onuma, Hajime
    Ito, Kagenori
    Mori, Keiichiro
    Sasaki, Hiroshi
    Miki, Jun
    Furuta, Akira
    Miki, Kenta
    Egawa, Shin
    PROSTATE, 2019, 79 (14) : 1604 - 1610
  • [40] The Association Between Radiographic Response and Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Receiving Chemotherapy
    Sonpavde, Guru
    Pond, Gregory R.
    Berry, William R.
    de Wit, Ronald
    Eisenberger, Mario A.
    Tannock, Ian F.
    Armstrong, Andrew J.
    CANCER, 2011, 117 (17) : 3963 - 3971
12345